IP Library Granted Patent US 9,693,975
Granted Patent B2
US 9,693,975 · App. 15/239,446 · Granted Jul 4, 2017

Bicyclic analgesic compounds

Inventor: Kevin Duane Bunker (San Diego, CA)
Assignee: Kalyra Pharmaceuticals, Inc.
A61K31/16A61K9/0014A61K9/0019A61K31/13A61K31/133A61K31/14A61K31/215A61K31/216A61K31/22A61K31/221A61K31/235A61K31/24A61K45/06C07C211/62C07C217/52C07C233/06C07C233/23C07C233/41C07C233/52C07C233/63C07C235/74C07C2102/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,975
App. No.
15/239,446
Granted
Jul 4, 2017
Kind
B2
Abstract

Analgesic compounds for treatment of pain or fever, comprising a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering the compounds.

Claims (19)

1. A compound of Formula 1:

wherein

R 1 is H, —CH 3 , CF 3 , or a substituted or unsubstituted (C 2 to C 5 ) lower alkyl;

R 2 is C(═Y)R 4 ;

R 3 is (C 1 to C 30 ) substituted or unsubstituted alkyl, alkenyl, cycloalkyl, cycloalkenyl, cycloalkynyl, heterocycle, heteroaryl, arylalkyl, alkylaryl or heteroarylalkyl;

R 4 is (C 1 to C 10 ) substituted or unsubstituted lower alkyl; and

Y is O.

2. The compound of claim 1 , wherein R 1 is H.

3. The compound of claim 1 , wherein R 1 is —CH 3 .

4. The compound of claim 1 , wherein R 2 is C(═Y)R 4 .

5. The compound of claim 1 , wherein R 3 is (C 1 to C 30 ) substituted alkyl.

6. The compound of claim 1 , wherein R 3 is (C 1 to C 30 ) unsubstituted alkyl.

7. The compound of claim 1 , wherein R 3 is alkenyl.

8. The compound of claim 1 , wherein R 3 is cycloalkyl.

9. The compound of claim 1 , wherein R 3 is cycloalkenyl.

10. The compound of claim 1 , wherein R 3 is heterocycle.

11. The compound of claim 1 , wherein R 3 is heteroaryl.

12. The compound of claim 1 , wherein R 3 is arylalkyl.

13. The compound of claim 1 , wherein R 3 is heteroarylalkyl.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2025
From: RECURIUM IP HOLDINGS, LLC
To: KTHERA, LLC
Reel/Frame 070653/0373 →
CHANGE OF NAME Recorded Jan 3, 2020
From: ZENO ROYALTIES & MILESTONES, LLC
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 051478/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2018
From: KALYRA PHARMACEUTICALS, INC.
To: ZENO ROYALTIES & MILESTONES, LLC
Reel/Frame 047693/0852 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2018
From: KALYRA PHARMACEUTICALS, INC.
To: ZENO ROYALTIES & MILESTONES, LLC
Reel/Frame 047414/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: BUNKER, KEVIN DUANE
To: KALYRA PHARMACEUTICALS, INC.
Reel/Frame 039474/0992 →
Continuity (3)
Continuation 14199567 · Mar 6, 2014
Provisional Application 61781580 · Mar 14, 2013
Related Publication 20160355462A1 · Dec 8, 2016